Remove Cell Biology Remove Drug Development Remove Pharmaceutical Companies
article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

In addition, these models at the current state are better for short term tests, over a week or two and cannot be used for acquiring data from long term drug exposures. Miniature organs as test beds for new drugs Organoids are miniature human organs with clusters of cells derived from stem cells and mimic specific tissues.

article thumbnail

AI At The Frontier: Empowering Early Career Professionals In Drug Discovery

Elrig

Harini Srinivasan is a Principal Scientific Associate at Serna Bio with over 10 years of research experience in academic institutions, health care organizations and pharmaceutical companies. Driven by an interest in drug discovery Millie joined AstraZeneca after completion of her PhD at the end of 2020.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Discovering an Antimalarial Drug in Mao’s China

Codon

Department of Defense administered mefloquine, the synthetic drug developed at Walter Reed in the U.S., only issued “the strongest ‘black box’ warning” against the drug in 2013. have been poured into replicating work already done” by Chinese scientists decades ago. Nobody had an answer.

Drugs 136
article thumbnail

Guest Blog: Reflecting on the 2024 Society of Toxicology of Canada Symposium, by Ria Falvo, Director, Reporting

Alta Sciences

A non-profit organization, STC was founded in 1965 with 15 scientists from Montral-based pharmaceutical companies. It owned the societal name of the Canadian Association for Research on Drug Safety. The STC is an intimate gathering of scientists with a fervor to acquire and apply knowledge in toxicology.